Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.06 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced in astrocytes (17 nCPM) | 1.00 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 96 | 0.91 |
| pathways Reactome | 1 pathway; mostly other | 0.30 |
No case: the score is under the bar. Receipt 4550
Sealed predictions
- FGF11 in astrocytes, braakn/a → n/areceipt 4556
- FGF11 in dopamine neurons, braak-0.06 (p 0.874) → -0.41 (p 0.273)receipt 4557
Swarm cases
receipt 4557: FGF11 in dopamine neurons, braak
- power
- full sample -0.46 (p 0.054, n 18), 95% CI -0.76 to +0.01. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.47 (p 0.051, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.47 (p 0.047, n 18). not the mix.
- skeptic
- leave-one-out range -0.55 to -0.39, sign flips 0; without severely affected donors -0.46 (p 0.054, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for FGF11 in dopamine neurons.
case closed: nothing better to follow up.
receipt 4556: FGF11 in astrocytes, braak
- cell type
- FGF11 is not measured in astrocytes; looking elsewhere.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for FGF11 in astrocytes.
case closed: nothing better to follow up.
Receipts
loading the receipts